Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ðenana Miodragović"'
Autor:
Ðenana Miodragović, Wenan Qiang, Zohra Sattar Waxali, Željko Vitnik, Vesna Vitnik, Yi Yang, Annie Farrell, Matthew Martin, Justin Ren, Thomas V. O’Halloran
Publikováno v:
Molecules, Vol 26, Iss 17, p 5421 (2021)
Patients with triple negative breast cancers (TNBCs)—highly aggressive tumors that do not express estrogen, progesterone, and human epidermal growth factor 2 receptors—have limited treatment options. Fewer than 30% of women with metastatic TNBC s
Externí odkaz:
https://doaj.org/article/2ece449ef2a24b50aa5f6905ee4d2a06
Autor:
Annie Farrell, Yi Yang, Željko J. Vitnik, Vesna D. Vitnik, Justin Ren, Matthew Martin, Zohra Sattar Waxali, Wenan Qiang, Ðenana Miodragović, Thomas V. O'Halloran
Publikováno v:
Molecules
Volume 26
Issue 17
Molecules, Vol 26, Iss 5421, p 5421 (2021)
Volume 26
Issue 17
Molecules, Vol 26, Iss 5421, p 5421 (2021)
Patients with triple negative breast cancers (TNBCs)—highly aggressive tumors that do not express estrogen, progesterone, and human epidermal growth factor 2 receptors—have limited treatment options. Fewer than 30% of women with metastatic TNBC s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19f56f547ff07ef1ae747f657b61ba63
https://doi.org/10.3390/molecules26175421
https://doi.org/10.3390/molecules26175421
Autor:
Thomas V. O'Halloran, Abraham Bogachkov, Zohra Sattar Waxali, Ðenana Miodragović, Elden P. Swindell
Publikováno v:
Inorganica Chim Acta
Platinum drugs (cisplatin, oxaliplatin, and carboplatin) and arsenic trioxide are the only commercial inorganic non-radioactive anticancer drugs approved by the US Food and Drug Administration. Numerous efforts are underway to take advantage of the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ec716a1057ae25ab5c745929826b29b
https://doi.org/10.1016/j.ica.2019.119030
https://doi.org/10.1016/j.ica.2019.119030
Autor:
Josh W. Kurutz, Charlotte L. Stern, Thomas V. O'Halloran, Ðenana Miodragović, Andrew P. Mazar, Irawati Kandela, Jeremy A. Quentzel, Richard W. Ahn
Publikováno v:
Angewandte Chemie. 125:10949-10952
The first molecular adducts of platinum and arsenic based anticancer drugs - arsenoplatins - show unanticipated structure, substitution chemistry, and cellular cytotoxicity. The PtII-AsIII bonds in these complexes are stable in aqueous solution and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fc98055158bb5b206a18709afb20a52
https://doi.org/10.1002/ange.201303251
https://doi.org/10.1002/ange.201303251